Latest Breaking News On - Taiwan region - Page 5 : comparemela.com

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Macau generalMeixiang chenClin nephrolUrol nephrolChina medical system holdings limitedKidney international supplementsWinhealth investment hk limitedNational medical products administrationChina medical system holdings ltdConference of chinese nephrologist associationVifor fresenius medical care renal pharma ltdMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharmaWinhealth investmentLicense agreement

China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®

China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Macau generalMeixiang chenUrol nephrolClin nephrolKidney international supplementsInternational urologyNational medical products administrationWinhealth investment hk limitedConference of chinese nephrologist associationChina medical system holdings ltdVifor fresenius medical care renal pharma ltdNational reimbursement drug listChina medical system holdings limitedMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharma

China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro

04.02.2024 - SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 2 February 2024, the Group through its wholly-owned subsidiary entered into a Novation Agreement (the . Seite 1

Macau generalWinhealth investment hk limitedVifor fresenius medical care renal pharma ltdChina medical system holdings limitedMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharmaWinhealth investmentLicense agreementMainland chinaHong kong special administrative regionMacao special administrative regionTaiwan regionChina medical system holdings chartHina medical system holdings kursHina medical system holdings aktie

China Medical System (00867） Obtained Exclusive License of

SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 2 February.

Macau generalUrol nephrolClin nephrolMeixiang chenKidney international supplementsChina medical system holdings limitedChina medical system holdings ltdInternational urologyVifor fresenius medical care renal pharma ltdNational reimbursement drug listWinhealth investment hk limitedNational medical products administrationConference of chinese nephrologist associationMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharma

China Medical System (00867） Obtained Exclusive License Of A First-Line Phosphate-Lowering Drug Velphoro®

China Medical System (00867） Obtained Exclusive License Of A First-Line Phosphate-Lowering Drug Velphoro®
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Macau generalClin nephrolChinj nephrolMeixiang chenUrol nephrolChina medical system holdings ltdConference of chinese nephrologist associationKidney international supplementsNational reimbursement drug listInternational urologyChina medical system holdings limitedWinhealth investment hk limitedVifor fresenius medical care renal pharma ltdNational medical products administrationMedical system holdings limitedNovation agreement